The Community Guide

- gsearch

Search Results

Narrow Results:

2024 2
2023 2
2018 2
2015 4
2014 1
2013 1
2012 1
2011 1
2005 1

HIV Outpatient Study Investigators 1

Journal Article 15

1 - 15 of 15 Results

Refine Results

Refine Results:

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing

CITE Title : Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing Personal Author(s) : Shrivastava-Ranjan, Punya;Flint, Mike;Bergeron, Éric;McElroy, Anita K.;Chatterjee, Payel;Albariño, César G.;Nichol, Stuart T.;Spiropoulou, Christina F.; Published Date : May 01 2018 Source : mBio. 9(3). URL : https://stacks.cdc.gov/view/cdc/53865 Shrivastava-Ranjan, Punya et al. (2018). Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing. 9(3). Shrivastava-Ranjan, Punya et al. "Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing" 9, no. 3 (2018) Shrivastava-Ranjan, Punya et al. "Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing" vol. 9, no. 3, 2018 Export RIS Citation Information.

:

Shrivastava-Ranjan, Punya ;

Flint, Mike

May 01 2018 | mBio. 9(3).

:

Ebola virus (EBOV) infection is a major public health concern due to high fatality rates and limited effective treatments. Statins, widely used choles...
Clinical Features and Patient Management of Lujo Hemorrhagic Fever

CITE Title : Clinical Features and Patient Management of Lujo Hemorrhagic Fever Personal Author(s) : Sewlall, Nivesh H.;Richards, Guy;Duse, Adriano;Swanepoel, Robert;Paweska, Janusz;Blumberg, Lucille;Dinh, Thu Ha;Bausch, Daniel; Published Date : November 13 2014 Source : PLoS Negl Trop Dis. 2014; 8(11) URL : https://stacks.cdc.gov/view/cdc/89854 Sewlall, Nivesh H. et al. (2014). Clinical Features and Patient Management of Lujo Hemorrhagic Fever. 8(11). Sewlall, Nivesh H. et al. "Clinical Features and Patient Management of Lujo Hemorrhagic Fever" 8, no. 11 (2014) Sewlall, Nivesh H. et al. "Clinical Features and Patient Management of Lujo Hemorrhagic Fever" vol. 8, no. 11, 2014 Export RIS Citation Information.

:

Sewlall, Nivesh H. ;

Richards, Guy

November 13 2014 | PLoS Negl Trop Dis. 2014; 8(11)

:

BackgroundIn 2008 a nosocomial outbreak of five cases of viral hemorrhagic fever due to a novel arenavirus, Lujo virus, occurred in Johannesburg, Sout...
Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022

CITE Title : Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022 Personal Author(s) : Sekkarie, Ahlia;Park, Soyoun;Therrien, Nicole L.;Jackson, Sandra L.;Woodruff, Rebecca C.;Attipoe-Dorcoo, Sharon;Yang, Peter K.;Sperling, Laurence;Loustalot, Fleetwood;Thompson-Paul, Angela M.; Published Date : 4 2023;4-2023; Source : Am J Prev Med. 64(4):561-566 URL : https://stacks.cdc.gov/view/cdc/126185 Sekkarie, Ahlia et al. (2023). Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022. 64(4). Sekkarie, Ahlia et al. "Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022" 64, no. 4 (2023) Sekkarie, Ahlia et al. "Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022" vol. 64, no. 4, 2023 Export RIS Citation Information.

:

Sekkarie, Ahlia ;

Park, Soyoun

4 2023 | Am J Prev Med. 64(4):561-566

:

Introduction:Almost one-third of U.S. adults have elevated low-density lipid cholesterol (LDL-C) increasing their risk of atherosclerotic cardiovascul...
A prognostic model based on readily available clinical data enriched a preemptive pharmacogenetic testing program

CITE Title : A prognostic model based on readily available clinical data enriched a preemptive pharmacogenetic testing program Personal Author(s) : Schildcrout, Jonathan S.;Shi, Yaping;Danciu, Ioana;Bowton, Erica;Field, Julie R.;Pulley, Jill M.;Basford, Melissa;Gregg, William;Cowan, James;Harrell, Frank E.;Roden, Dan M.;Peterson, Josh F.;Denny, Joshua C.; Published Date : Nov 25 2015 Source : J Clin Epidemiol. 72:107-115. URL : https://stacks.cdc.gov/view/cdc/38371 Schildcrout, Jonathan S. et al. (2015). A prognostic model based on readily available clinical data enriched a preemptive pharmacogenetic testing program. 72 Schildcrout, Jonathan S. et al. "A prognostic model based on readily available clinical data enriched a preemptive pharmacogenetic testing program" 72 (2015) Schildcrout, Jonathan S. et al. "A prognostic model based on readily available clinical data enriched a preemptive pharmacogenetic testing program" vol. 72, 2015 Export RIS Citation Information.

:

Schildcrout, Jonathan S. ;

Shi, Yaping

Nov 25 2015 | J Clin Epidemiol. 72:107-115.

:

ObjectiveWe describe the development, implementation, and evaluation of a model to preemptively select patients for genotyping based on medication exp...
Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study

CITE Title : Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study Personal Author(s) : Walker, Evan J;Ko, Andrew H;Holly, Elizabeth A;Bracci, Paige M; Published Date : Feb 03 2015 Source : Cancer. 121(8):1287-1294. URL : https://stacks.cdc.gov/view/cdc/31383 Walker, Evan J et al. (2015). Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study. 121(8). Walker, Evan J et al. "Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study" 121, no. 8 (2015) Walker, Evan J et al. "Statin use and risk of pancreatic cancer: Results from a large clinic-based case-control study" vol. 121, no. 8, 2015 Export RIS Citation Information.

:

Walker, Evan J ;

Ko, Andrew H

Feb 03 2015 | Cancer. 121(8):1287-1294.

:

BackgroundStatins are cholesterol-lowering medications with pleiotropic effects including alterations in growth signaling as well as immunomodulatory ...
Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients

CITE Title : Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients Personal Author(s) : Lee, Nelson;Leo, Yee-Sin;Cao, Bin;Chan, Paul K.S.;Kyaw, W.M.;Uyeki, Timothy M.;Tam, Wilson W.S.;Cheung, Catherine S.K.;Yung, Irene M.H.;Li, Hui;Gu, Li;Yingmei, Liu;Zhenjia, Liu;Jiuxin, Qu;Hui, David S.C.; Published Date : January 08 2015 Source : Eur Respir J. 45(6):1642-1652 URL : https://stacks.cdc.gov/view/cdc/80383 Lee, Nelson et al. (2015). Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. 45(6). Lee, Nelson et al. "Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients" 45, no. 6 (2015) Lee, Nelson et al. "Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients" vol. 45, no. 6, 2015 Export RIS Citation Information.

:

Lee, Nelson ;

Leo, Yee-Sin

January 08 2015 | Eur Respir J. 45(6):1642-1652

:

We aimed to study factors influencing outcomes of adults hospitalised for seasonal and pandemic influenza. Individual-patient data from three Asian ...
Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk

CITE Title : Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk Personal Author(s) : Ivanova, Anna A.;Gardner, Michael S.;Kusovschi, Jennifer D.;Parks, Bryan A.;Schieltz, David M.;Bareja, Akshay;McGarrah, Robert W.;Kraus, William E.;Kuklenyik, Zsuzsanna;Pirkle, James L.;Barr, John R.; Published Date : 3 02 2024;3-02-; Source : Clin Chem. 70(3):528-537 URL : https://stacks.cdc.gov/view/cdc/160184 Ivanova, Anna A. et al. (2024). Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk. 70(3). Ivanova, Anna A. et al. "Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk" 70, no. 3 (2024) Ivanova, Anna A. et al. "Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk" vol. 70, no. 3, 2024 Export RIS Citation Information.

:

Ivanova, Anna A.

;

Gardner, Michael S.

3 02 2024 | Clin Chem. 70(3):528-537

:

BACKGROUND:Lipid profiling is central for coronary artery disease (CAD) risk assessment. Nonadherence or unreported use of lipid-lowering drugs, parti...
Recommended and Observed Statin Use among U.S. Adults – National Health and Nutrition Examination Survey, 2011–2018

CITE Title : Recommended and Observed Statin Use among U.S. Adults – National Health and Nutrition Examination Survey, 2011–2018 Personal Author(s) : Thompson-Paul, Angela M.;Gillespie, Cathleen;Wall, Hilary K.;Loustalot, Fleetwood;Sperling, Laurence;Hong, Yuling; Published Date : 2023;Mar-Apr 2023; Source : J Clin Lipidol. 17(2):225-235 URL : https://stacks.cdc.gov/view/cdc/127172 Thompson-Paul, Angela M. et al. (2023). Recommended and Observed Statin Use among U.S. Adults – National Health and Nutrition Examination Survey, 2011–2018. 17(2). Thompson-Paul, Angela M. et al. "Recommended and Observed Statin Use among U.S. Adults – National Health and Nutrition Examination Survey, 2011–2018" 17, no. 2 (2023) Thompson-Paul, Angela M. et al. "Recommended and Observed Statin Use among U.S. Adults – National Health and Nutrition Examination Survey, 2011–2018" vol. 17, no. 2, 2023 Export RIS Citation Information.

:

Thompson-Paul, Angela M. ;

Gillespie, Cathleen

2023 | J Clin Lipidol. 17(2):225-235

:

Background:The American College of Cardiology/American Heart Association Blood Cholesterol Guideline was published in 2013 (2013 Cholesterol Guideline...
Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study

CITE Title : Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study Personal Author(s) : Lichtenstein, Kenneth A.;Hart, Rachel L. D.;Wood, Kathleen C.;Bozzette, Samuel;Buchacz, Kate;Brooks, John T.; Corporate Authors(s) : HIV Outpatient Study Investigators Published Date : 7 1 2015;7-1-; Source : J Acquir Immune Defic Syndr. 69(3):306-311 URL : https://stacks.cdc.gov/view/cdc/36697 Lichtenstein, Kenneth A. et al. (2015). Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study. 69(3). Lichtenstein, Kenneth A. et al. "Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study" 69, no. 3 (2015) Lichtenstein, Kenneth A. et al. "Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study" vol. 69, no. 3, 2015 Export RIS Citation Information.

:

Lichtenstein, Kenneth A. ;

Hart, Rachel L. D.

7 1 2015 | J Acquir Immune Defic Syndr. 69(3):306-311

:

IntroductionStatin therapy is effective in the prevention of cardiovascular disease in the general population but has been shown to modestly increase ...
Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014)

CITE Title : Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014) Personal Author(s) : Bucholz, Emily M.;Rodday, Angie Mae;Kolor, Katherine;Khoury, Muin J.;de Ferranti, Sarah D.; Published Date : 5 22 2018;5-22-; Source : Circulation. 137(21):2218-2230 URL : https://stacks.cdc.gov/view/cdc/76112 Bucholz, Emily M. et al. (2018). Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014). 137(21). Bucholz, Emily M. et al. "Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014)" 137, no. 21 (2018) Bucholz, Emily M. et al. "Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999–2014)" vol. 137, no. 21, 2018 Export RIS Citation Information.

:

Bucholz, Emily M. ;

Rodday, Angie Mae

5 22 2018 | Circulation. 137(21):2218-2230

:

BACKGROUND:Familial hypercholesterolemia (FH) and other extreme elevations in low-density lipoprotein cholesterol significantly increase the risk of a...
The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010

CITE Title : The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010 Personal Author(s) : Stark Casagrande, Sarah;Fradkin, Judith E.;Saydah, Sharon H.;Rust, Keith F.;Cowie, Catherine C.; Published Date : Feb 15 2013 Source : Diabetes Care. 2013; 36(8):2271-2279. URL : https://stacks.cdc.gov/view/cdc/24459 Stark Casagrande, Sarah et al. (2013). The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010. 36(8). Stark Casagrande, Sarah et al. "The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010" 36, no. 8 (2013) Stark Casagrande, Sarah et al. "The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People With Diabetes, 1988–2010" vol. 36, no. 8, 2013 Export RIS Citation Information.

:

Stark Casagrande, Sarah ;

Fradkin, Judith E.

Feb 15 2013 | Diabetes Care. 2013; 36(8):2271-2279.

:

OBJECTIVETo determine the prevalence of people with diabetes who meet hemoglobin A1c (A1C), blood pressure (BP), and LDL cholesterol (ABC) recommendat...
Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: SEER-Medicare 2007–2015

CITE Title : Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: SEER-Medicare 2007–2015 Personal Author(s) : Hussain, Maryam R.;Abdelgadir, Omer;Polychronopoulou, Efstathia;Tsilidis, Konstantinos K.;Alzweri, Laith;Villasante-Tezanos, Alejandro;Baillargeon, Jacques;Canfield, Steven;Kuo, Yong-Fang;Lopez, David S.; Published Date : 11 2024;11-2024; Source : Andrology. 12(8):1697-1711 URL : https://stacks.cdc.gov/view/cdc/160683 Hussain, Maryam R. et al. (2024). Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: SEER-Medicare 2007–2015. 12(8). Hussain, Maryam R. et al. "Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: SEER-Medicare 2007–2015" 12, no. 8 (2024) Hussain, Maryam R. et al. "Evaluating the impact of pre-diagnostic use of statins and testosterone replacement therapy on mortality outcomes in older men with hormone-related cancers: SEER-Medicare 2007–2015" vol. 12, no. 8, 2024 Export RIS Citation Information.

:

Hussain, Maryam R.

;

Abdelgadir, Omer

11 2024 | Andrology. 12(8):1697-1711

:

Background:The link between the pre-diagnostic use of statins and testosterone replacement therapy (TTh) and their impact on hormone-related cancers (...

Public Access Available on:

November 01, 2025
Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study

CITE Title : Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study Personal Author(s) : Lutski, Miriam;Shalev, Varda;Porath, Avi;Chodick, Gabriel; Published Date : 2012 Source : Prev Chronic Dis. 9. URL : https://stacks.cdc.gov/view/cdc/19740 Journal Title : Preventing Chronic Disease (PCD) Lutski, Miriam et al. (2012). Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study. 9 Lutski, Miriam et al. "Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study" 9 (2012) Lutski, Miriam et al. "Continuation With Statin Therapy and the Risk of Primary Cancer: A Population-Based Study" vol. 9, 2012 Export RIS Citation Information.

:

Lutski, Miriam ;

Shalev, Varda

2012 | Prev Chronic Dis. 9.

:

IntroductionStudies have suggested that statins may inhibit tumor cell growth and possibly prevent carcinogenesis. The objective of this study was to ...
Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings

CITE Title : Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings Personal Author(s) : O’Connor, Patrick J.;Gray, Richard J.;Maciosek, Michael V.;Fillbrandt, Kelly M.;DeFor, Terese A.;Alexander, Charles M.;Weiss, Thomas W.;Teutsch, Steven M.; Published Date : Jun 15 2005 Source : Prev Chronic Dis. 2005; 2(3). URL : https://stacks.cdc.gov/view/cdc/19943 Journal Title : Preventing Chronic Disease (PCD) O’Connor, Patrick J. et al. (2005). Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings. 2(3). O’Connor, Patrick J. et al. "Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings" 2, no. 3 (2005) O’Connor, Patrick J. et al. "Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings" vol. 2, no. 3, 2005 Export RIS Citation Information.

:

O’Connor, Patrick J. ;

Gray, Richard J.

Jun 15 2005 | Prev Chronic Dis. 2005; 2(3).

:

IntroductionTherapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, has proven to be effective in the treatment...
A Cost-Benefit Analysis of Lipid Standardization in the United States

CITE Title : A Cost-Benefit Analysis of Lipid Standardization in the United States Personal Author(s) : Hoerger, Thomas J.;Wittenborn, John S.;Young, Walter; Published Date : Oct 17 2011 Source : Prev Chronic Dis. 2011; 8(6). URL : https://stacks.cdc.gov/view/cdc/20639 Journal Title : Preventing Chronic Disease (PCD) Hoerger, Thomas J. et al. (2011). A Cost-Benefit Analysis of Lipid Standardization in the United States. 8(6). Hoerger, Thomas J. and Wittenborn, John S. and Young, Walter "A Cost-Benefit Analysis of Lipid Standardization in the United States" 8, no. 6 (2011) Hoerger, Thomas J. et al. "A Cost-Benefit Analysis of Lipid Standardization in the United States" vol. 8, no. 6, 2011 Export RIS Citation Information.

:

Hoerger, Thomas J. ;

Wittenborn, John S.

Oct 17 2011 | Prev Chronic Dis. 2011; 8(6).

:

IntroductionBy improving lipid standardization, the Centers for Disease Control and Prevention's (CDC's) Lipid Standardization Program and Cholesterol...